Science & Technology
DirectBio is pioneering a new approach to molecular diagnostics based on CRISPR enzymes.
We harness the speed, specificity, and sensitivity of natural and AI-engineered CRISPR enzymes to create diagnostic assays that are simpler and more scalable than conventional PCR due to the need for fewer reagents, no RNA or DNA extraction, and no amplification or reverse transcription.
Applications
Team
The team is an experienced group coming from science and technology with academic and industry background, as well as from business with entrepreneurial and leadership background ranging from innovative emerging to the world’s largest life science companies.